-
Ecopipam (development
codes SCH-39166, EBS-101, and PSYRX-101) is a
dopamine antagonist which is
under development for the
treatment of Lesch–Nyhan syndrome...
- No
other D1
receptor antagonists have been
approved for
clinical use.
Ecopipam is a
selective D1-like
receptor antagonist that has been
studied clinically...
-
divided into D1-like
receptor antagonists and D2-like
receptor antagonists.
Ecopipam is an
example of a D1-like
receptor antagonist. At low doses, dopamine...
-
calcium Dodecylbenzenesulfonic acid
Dronabinol Droxidopa Eburnamonine Ecopipam Enzacamene Epothilone B
Erythromycin Famprofazone Febantel Felodipine Fenbendazole...
-
neostriatum (i.e.,
dorsal striatum).
Dopamine D1
receptor antagonists like
ecopipam and
dopamine D2
receptor antagonists like
haloperidol have
similar amotivational...
-
Quetiapine Risperidone Tefludazine Zicronapine Ziprasidone Zotepine Others:
Berupipam Ecopipam EEDQ
Metitepine (methiothepin)
Odapipam Perlapine SCH-23390...
- in
susceptible individuals antipsychotics/dopamine
antagonists such as
ecopipam and
reserpine cholecystokinin (CCK) (especially the
tetrapeptide and octapeptide...
-
calcium Dodecylbenzenesulfonic acid
Dronabinol Droxidopa Eburnamonine Ecopipam Enzacamene Epothilone B
Erythromycin Famprofazone Febantel Felodipine Fenbendazole...
-
Quetiapine Risperidone Tefludazine Zicronapine Ziprasidone Zotepine Others:
Berupipam Ecopipam EEDQ
Metitepine (methiothepin)
Odapipam Perlapine SCH-23390...
-
phenindamine (see MPTP) Tetracyclic: maprotiline, dihydrexidine, butaclamol,
ecopipam Tetrahydrobenzazepine: SKF-83959, SKF-82958, SKF-81297, SKF 38393, fenoldopam...
